IP Library Granted Patent US 10,550,165
Granted Patent B2
US 10,550,165 · App. 15/691,017 · Granted Feb 4, 2020

Peptide for inducing regeneration of tissue and use thereof

Inventors: Katsuto Tamai (Osaka, JP); Takehiko Yamazaki (Osaka, JP); Tsutomu Kanezaki (Osaka, JP); Shigeru Sakurai (Osaka, JP); Yukiko Noguchi (Osaka, JP); Mayumi Endo (Osaka, JP); Natsumi Hamabuchi (Osaka, JP); Kana Naito (Osaka, JP)
Assignees: STEMRIM INC.; OSAKA UNIVERSITY
C07K14/4705C07K14/4702A61K38/17
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,550,165
App. No.
15/691,017
Granted
Feb 4, 2020
Kind
B2
Abstract

(Objective) An objective of the present invention is to provide therapeutic agents that, in association with stimulation of PDGFRα-positive cells such as bone marrow mesenchymal stem cells, promote their mobilization into blood and accumulation in a damaged tissue, and induce tissue regeneration in a living body. (Means for solution) Multiple peptides were synthesized, and the migration-promoting activity of each peptide was evaluated. As a result, the present inventors successfully identified multiple peptides that have migration-promoting activity on a PDGFRα-positive bone marrow mesenchymal stem cell line (MSC-1). Further, the present inventors confirmed that the identified peptides also have migration-promoting activity on skin fibroblasts, which are PDGFRα-positive cells.

Claims (66)

1. A peptide selected from the group consisting of:

A) a peptide that consists of a portion of an HMGB1 protein of the amino acid sequence of SEQ ID NO: 1 and has an activity of stimulating migration of a cell, wherein the peptide consists of the whole or part of the amino acid sequence of positions 1 to 52 in the amino acid sequence of SEQ ID NO: 1, and comprises any of the amino acid sequences below:

(1) the amino acid sequence of position 2 to position 25 in the amino acid sequence of SEQ ID NO: 1;

(2) the amino acid sequence of position 11 to position 34 in the amino acid sequence of SEQ ID NO:1; and

(3) the amino acid sequence of position 17 to position 44 in the amino acid sequence of SEQ ID NO:1;

B) a peptide that consists of a portion of an HMGB1 protein of the amino acid sequence of SEQ ID NO: 1 and has an activity of stimulating migration of a cell, wherein the peptide consists of the whole or part of the amino acid sequence of positions 1 to 25 or positions 17 to 44 in the amino acid sequence of SEQ ID NO: 1, and comprises the amino acid sequence of position 17 to position 25 in the amino acid sequence of SEQ ID NO: 1;

C) a peptide that consists of a portion of an HMGB1 protein of the amino acid sequence of SEQ ID NO: 1 and has an activity of stimulating migration of a cell, wherein the peptide consists of the whole or part of the amino acid sequence of positions 1 to 205 in the amino acid sequence of SEQ ID NO: 1, and comprises the amino acid sequence of position 89 to position 195 in the amino acid sequence of SEQ ID NO: 1;

D) a peptide that consists of a portion of an HMGB1 protein of the amino acid sequence of SEQ ID NO: 1 and has an activity of stimulating migration of a cell, wherein the peptide consists of the whole or part of the amino acid sequence of positions 45 to 215 in the amino acid sequence of SEQ ID NO: 1, and comprises any of the amino acid sequences below:

(1) the amino acid sequence of position 85 to position 169 in the amino acid sequence of SEQ ID NO: 1;

(2) the amino acid sequence of position 89 to position 185 in the amino acid sequence of SEQ ID NO: 1; and

(3) the amino acid sequence of position 93 to position 215 in the amino acid sequence of SEQ ID NO: 1; and

E) a peptide that consists of any of the amino acid sequences below:

(1) the amino acid sequence of position 1 to position 44 in the amino acid sequence of SEQ ID NO: 1;

(2) the amino acid sequence of position 1 to position 70 in the amino acid sequence of SEQ ID NO: 1;

(3) the amino acid sequence of position 1 to position 84 in the amino acid sequence of SEQ ID NO:1;

(4) the amino acid sequence of position 1 to position 170 in the amino acid sequence of SEQ ID NO: 1;

(5) the amino acid sequence of position 1 to position 185 in the amino acid sequence of SEQ ID NO: 1;

(6) the amino acid sequence of position 1 to position 195 in the amino acid sequence of SEQ ID NO: 1;

(7) the amino acid sequence of position 2 to position 44 in the amino acid sequence of SEQ ID NO: 1;

(8) the amino acid sequence of position 2 to position 70 in the amino acid sequence of SEQ ID NO: 1,

(9) the amino acid sequence of position 2 to position 84 in the amino acid sequence of SEQ ID NO: 1;

(10) the amino acid sequence of position 2 to position 170 in the amino acid sequence of SEQ ID NO: 1;

(11) the amino acid sequence of position 2 to position 185 in the amino acid sequence of SEQ ID NO: 1;

(12) the amino acid sequence of position 2 to position 195 in the amino acid sequence of SEQ ID NO: 1;

(13) the amino acid sequence of position 17 to position 25 in the amino acid sequence of SEQ ID NO: 1;

(14) the amino acid sequence of position 45 to position 84 in the amino acid sequence of SEQ ID NO: 1;

(15) the amino acid sequence of position 85 to position 169 in the amino acid sequence of SEQ ID NO: 1;

(16) the amino acid sequence of position 89 to position 185 in the amino acid sequence of SEQ ID NO: 1;

(17) the amino acid sequence of position 89 to position 195 in the amino acid sequence of SEQ ID NO: 1; and

(18) the amino acid sequence of position 93 to position 215 in the amino acid sequence of SEQ ID NO: 1.

2. The peptide of claim 1 , that consists of a portion of an HMGB1 protein of the amino acid sequence of SEQ ID NO: 1 and has an activity of stimulating migration of a cell, wherein the peptide consists of the whole or part of the amino acid sequence of positions 1 to 52 in the amino acid sequence of SEQ ID NO: 1, and comprises any of the amino acid sequences below:

(1) the amino acid sequence of position 2 to position 25 in the amino acid sequence of SEQ ID NO: 1;

(2) the amino acid sequence of position 11 to position 34 in the amino acid sequence of SEQ ID NO:1; and

(3) the amino acid sequence of position 17 to position 44 in the amino acid sequence of SEQ ID NO:1.

3. The peptide of claim 1 , that consists of a portion of an HMGB1 protein of the amino acid sequence of SEQ ID NO: 1 and has an activity of stimulating migration of a cell, wherein the peptide consists of the whole or part of the amino acid sequence of positions 1 to 25 or positions 17 to 44 in the amino acid sequence of SEQ ID NO: 1, and comprises the amino acid sequence of position 17 to position 25 in the amino acid sequence of SEQ ID NO: 1.

4. The peptide of claim 1 , that consists of a portion of an HMGB1 protein of the amino acid sequence of SEQ ID NO: 1 and has an activity of stimulating migration of a cell, wherein the peptide consists of the whole or part of the amino acid sequence of positions 1 to 205 in the amino acid sequence of SEQ ID NO: 1, and comprises the amino acid sequence of position 89 to position 195 in the amino acid sequence of SEQ ID NO: 1.

5. The peptide of claim 1 , that consists of a portion of an HMGB1 protein of the amino acid sequence of SEQ ID NO: 1 and has an activity of stimulating migration of a cell, wherein the peptide consists of the whole or part of the amino acid sequence of positions 45 to 215 in the amino acid sequence of SEQ ID NO: 1, and comprises any of the amino acid sequences below:

(1) the amino acid sequence of position 85 to position 169 in the amino acid sequence of SEQ ID NO: 1;

(2) the amino acid sequence of position 89 to position 185 in the amino acid sequence of SEQ ID NO: 1; and

(3) the amino acid sequence of position 93 to position 215 in the amino acid sequence of SEQ ID NO: 1.

6. The peptide according to claim 1 , that consists of any of the amino acid sequences below:

(1) the amino acid sequence of position 1 to position 44 in the amino acid sequence of SEQ ID NO: 1;

(2) the amino acid sequence of position 1 to position 70 in the amino acid sequence of SEQ ID NO: 1,

(3) the amino acid sequence of position 1 to position 84 in the amino acid sequence of SEQ ID NO:1;

(4) the amino acid sequence of position 1 to position 170 in the amino acid sequence of SEQ ID NO: 1;

(5) the amino acid sequence of position 1 to position 185 in the amino acid sequence of SEQ ID NO: 1;

(6) the amino acid sequence of position 1 to position 195 in the amino acid sequence of SEQ ID NO: 1;

(7) the amino acid sequence of position 2 to position 44 in the amino acid sequence of SEQ ID NO: 1;

(8) the amino acid sequence of position 2 to position 70 in the amino acid sequence of SEQ ID NO: 1;

(9) the amino acid sequence of position 2 to position 84 in the amino acid sequence of SEQ ID NO: 1;

(10) the amino acid sequence of position 2 to position 170 in the amino acid sequence of SEQ ID NO: 1;

(11) the amino acid sequence of position 2 to position 185 in the amino acid sequence of SEQ ID NO: 1;

(12) the amino acid sequence of position 2 to position 195 in the amino acid sequence of SEQ ID NO: 1;

(13) the amino acid sequence of position 17 to position 25 in the amino acid sequence of SEQ ID NO: 1;

(14) the amino acid sequence of position 45 to position 84 in the amino acid sequence of SEQ ID NO: 1;

(15) the amino acid sequence of position 85 to position 169 in the amino acid sequence of SEQ ID NO: 1;

(16) the amino acid sequence of position 89 to position 185 in the amino acid sequence of SEQ ID NO: 1;

(17) the amino acid sequence of position 89 to position 195 in the amino acid sequence of SEQ ID NO: 1; and

(18) the amino acid sequence of position 93 to position 215 in the amino acid sequence of SEQ ID NO: 1.

7. The peptide of claim 1 , which is a synthetic peptide.

8. The peptide of claim 1 , which is a peptide produced using a cell.

9. The peptide of claim 1 , which is a peptide to which a tag is added.

10. The peptide of claim 1 , which is a peptide to which a tag-derived peptide fragment is added.

11. A composition comprising the peptide of claim 1 and a pharmaceutically acceptable carrier or additive.

12. The composition of claim 11 , wherein the pharmaceutically acceptable carrier or additive is selected from the group consisting of surfactant, excipient, colorant, perfume, preservative, stabilizer, buffer, suspending agent, isotonizing agent, binder, disintegrant, lubricant, flow promoter, and flavoring agent.

13. The composition of claim 11 , wherein the pharmaceutically acceptable carrier or additive is selected from the group consisting of light anhydrous silicic acid, lactose, crystalline cellulose, mannitol, starch, carmellose calcium, carmellose sodium, hydroxypropylcellulose, hydroxypropylmethylcellulose, polyvinylacetaldiethylamino acetate, polyvinylpyrrolidone, gelatin, medium-chain fatty acid triglyceride, polyoxyethylene hydrogenated castor oil 60, white sugar, carboxymethyl cellulose, corn starch, and inorganic salt.

Assignments (3)
CHANGE OF NAME Recorded Sep 18, 2018
From: GENOMIX CO., LTD.
To: STEMRIM INC.
Reel/Frame 047102/0685 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 4, 2018
From: TAMAI, KATSUTO
To: OSAKA UNIVERSITY
Reel/Frame 044536/0488 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 4, 2018
From: YAMAZAKI, TAKEHIKO; KANEZAKI, TSUTOMU; SAKURAI, SHIGERU; NOGUCHI, YUKIKO; ENDO, MAYUMI; HAMABUCHI, NATSUMI; NAITO, KANA
To: GENOMIX CO., LTD.
Reel/Frame 044536/0512 →
Priority Claims (2)
JP 2011-098270 · Apr 26, 2011 · national
JP 2011-219454 · Oct 3, 2011 · national
Continuity (2)
Continuation 14114395
Related Publication 20180072785A1 · Mar 15, 2018
Cited By (1)
US 12,421,498